These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 11257354)

  • 1. Genomic tools for gene and protein discovery in malaria: toward new vaccines.
    Carucci DJ
    Vaccine; 2001 Mar; 19(17-19):2315-8. PubMed ID: 11257354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards a blood-stage vaccine for malaria: are we following all the leads?
    Good MF
    Nat Rev Immunol; 2001 Nov; 1(2):117-25. PubMed ID: 11905819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA vaccine against malaria: a long way to go.
    Tuteja R
    Crit Rev Biochem Mol Biol; 2002; 37(1):29-54. PubMed ID: 11905546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico identification of genetically attenuated vaccine candidate genes for Plasmodium liver stage.
    Kumar H; Frischknecht F; Mair GR; Gomes J
    Infect Genet Evol; 2015 Dec; 36():72-81. PubMed ID: 26348884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine candidates for malaria: what's new?
    Takashima E; Morita M; Tsuboi T
    Expert Rev Vaccines; 2016; 15(1):1-3. PubMed ID: 26559316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A bicistronic DNA vaccine containing apical membrane antigen 1 and merozoite surface protein 4/5 can prime humoral and cellular immune responses and partially protect mice against virulent Plasmodium chabaudi adami DS malaria.
    Rainczuk A; Scorza T; Spithill TW; Smooker PM
    Infect Immun; 2004 Oct; 72(10):5565-73. PubMed ID: 15385453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering of Genetically Arrested Parasites (GAPs) For a Precision Malaria Vaccine.
    Kreutzfeld O; Müller K; Matuschewski K
    Front Cell Infect Microbiol; 2017; 7():198. PubMed ID: 28620583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic engineering of attenuated malaria parasites for vaccination.
    Khan SM; Janse CJ; Kappe SH; Mikolajczak SA
    Curr Opin Biotechnol; 2012 Dec; 23(6):908-16. PubMed ID: 22560204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmodium p25 and p28 surface proteins: potential transmission-blocking vaccines.
    Saxena AK; Wu Y; Garboczi DN
    Eukaryot Cell; 2007 Aug; 6(8):1260-5. PubMed ID: 17557884
    [No Abstract]   [Full Text] [Related]  

  • 10. Designing malaria vaccines to circumvent antigen variability.
    Ouattara A; Barry AE; Dutta S; Remarque EJ; Beeson JG; Plowe CV
    Vaccine; 2015 Dec; 33(52):7506-12. PubMed ID: 26475447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular vaccines for malaria.
    Bruder JT; Angov E; Limbach KJ; Richie TL
    Hum Vaccin; 2010 Jan; 6(1):54-77. PubMed ID: 20061792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetically modified Plasmodium highlights the potential of whole parasite vaccine strategies.
    Good MF
    Trends Immunol; 2005 Jun; 26(6):295-7. PubMed ID: 15922944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malaria vaccine developments.
    Moorthy VS; Good MF; Hill AV
    Lancet; 2004 Jan; 363(9403):150-6. PubMed ID: 14726170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malaria vaccine: candidate antigens, mechanisms, constraints and prospects.
    Carvalho LJ; Daniel-Ribeiro CT; Goto H
    Scand J Immunol; 2002 Oct; 56(4):327-43. PubMed ID: 12234254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards clinical development of a Pfs48/45-based transmission blocking malaria vaccine.
    Theisen M; Jore MM; Sauerwein R
    Expert Rev Vaccines; 2017 Apr; 16(4):329-336. PubMed ID: 28043178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can malaria DNA vaccines on their own be as immunogenic and protective as prime-boost approaches to immunization?
    Hoffman SL; Doolan DL
    Dev Biol (Basel); 2000; 104():121-32. PubMed ID: 11713810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmodium genomics: an approach for learning about and ending human malaria.
    Garrido-Cardenas JA; González-Cerón L; Manzano-Agugliaro F; Mesa-Valle C
    Parasitol Res; 2019 Jan; 118(1):1-27. PubMed ID: 30402656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of transgenic parasites in malaria vaccine research.
    Othman AS; Marin-Mogollon C; Salman AM; Franke-Fayard BM; Janse CJ; Khan SM
    Expert Rev Vaccines; 2017 Jul; 16(7):1-13. PubMed ID: 28525963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategy for development of a pre-erythrocytic Plasmodium falciparum DNA vaccine for human use.
    Hoffman SL; Doolan DL; Sedegah M; Aguiar JC; Wang R; Malik A; Gramzinski RA; Weiss WR; Hobart P; Norman JA; Margalith M; Hedstrom RC
    Vaccine; 1997 Jun; 15(8):842-5. PubMed ID: 9234529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccines. Searching for a parasite's weak spot.
    Taubes G
    Science; 2000 Oct; 290(5491):434-7. PubMed ID: 11183756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.